490 related articles for article (PubMed ID: 29627294)
1. β-arrestin-biased agonism of β-adrenergic receptor regulates Dicer-mediated microRNA maturation to promote cardioprotective signaling.
Teoh JP; Bayoumi AS; Aonuma T; Xu Y; Johnson JA; Su H; Weintraub NL; Tang Y; Kim IM
J Mol Cell Cardiol; 2018 May; 118():225-236. PubMed ID: 29627294
[TBL] [Abstract][Full Text] [Related]
2. β-arrestin1-biased β1-adrenergic receptor signaling regulates microRNA processing.
Kim IM; Wang Y; Park KM; Tang Y; Teoh JP; Vinson J; Traynham CJ; Pironti G; Mao L; Su H; Johnson JA; Koch WJ; Rockman HA
Circ Res; 2014 Feb; 114(5):833-44. PubMed ID: 24334028
[TBL] [Abstract][Full Text] [Related]
3.
Wang J; Pani B; Gokhan I; Xiong X; Kahsai AW; Jiang H; Ahn S; Lefkowitz RJ; Rockman HA
Mol Pharmacol; 2021 Dec; 100(6):568-579. PubMed ID: 34561298
[No Abstract] [Full Text] [Related]
4. A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes.
Bayoumi AS; Park KM; Wang Y; Teoh JP; Aonuma T; Tang Y; Su H; Weintraub NL; Kim IM
J Mol Cell Cardiol; 2018 Jan; 114():72-82. PubMed ID: 29122578
[TBL] [Abstract][Full Text] [Related]
5. Gα
Wang J; Hanada K; Staus DP; Makara MA; Dahal GR; Chen Q; Ahles A; Engelhardt S; Rockman HA
Nat Commun; 2017 Nov; 8(1):1706. PubMed ID: 29167435
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol-responsive microRNAs, miR-199a-3p and -214 protect cardiomyocytes from simulated ischemia-reperfusion injury.
Park KM; Teoh JP; Wang Y; Broskova Z; Bayoumi AS; Tang Y; Su H; Weintraub NL; Kim IM
Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H371-83. PubMed ID: 27288437
[TBL] [Abstract][Full Text] [Related]
7. Unique Positive Cooperativity Between the
Pani B; Ahn S; Rambarat PK; Vege S; Kahsai AW; Liu A; Valan BN; Staus DP; Costa T; Lefkowitz RJ
Mol Pharmacol; 2021 Nov; 100(5):513-525. PubMed ID: 34580163
[TBL] [Abstract][Full Text] [Related]
8. β-arrestin-biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction.
Carr R; Schilling J; Song J; Carter RL; Du Y; Yoo SM; Traynham CJ; Koch WJ; Cheung JY; Tilley DG; Benovic JL
Proc Natl Acad Sci U S A; 2016 Jul; 113(28):E4107-16. PubMed ID: 27354517
[TBL] [Abstract][Full Text] [Related]
9. The β-arrestin-biased β-adrenergic receptor blocker carvedilol enhances skeletal muscle contractility.
Kim J; Grotegut CA; Wisler JW; Mao L; Rosenberg PB; Rockman HA; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12435-12443. PubMed ID: 32414934
[TBL] [Abstract][Full Text] [Related]
10. A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling.
Wisler JW; DeWire SM; Whalen EJ; Violin JD; Drake MT; Ahn S; Shenoy SK; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16657-62. PubMed ID: 17925438
[TBL] [Abstract][Full Text] [Related]
11. Pepducin-mediated cardioprotection via β-arrestin-biased β2-adrenergic receptor-specific signaling.
Grisanti LA; Thomas TP; Carter RL; de Lucia C; Gao E; Koch WJ; Benovic JL; Tilley DG
Theranostics; 2018; 8(17):4664-4678. PubMed ID: 30279730
[TBL] [Abstract][Full Text] [Related]
12. Quantification of beta adrenergic receptor subtypes in beta-arrestin knockout mouse airways.
Hegde A; Strachan RT; Walker JK
PLoS One; 2015; 10(2):e0116458. PubMed ID: 25658948
[TBL] [Abstract][Full Text] [Related]
13. Induction of cardiac fibrosis by β-blocker in G protein-independent and G protein-coupled receptor kinase 5/β-arrestin2-dependent Signaling pathways.
Nakaya M; Chikura S; Watari K; Mizuno N; Mochinaga K; Mangmool S; Koyanagi S; Ohdo S; Sato Y; Ide T; Nishida M; Kurose H
J Biol Chem; 2012 Oct; 287(42):35669-35677. PubMed ID: 22888001
[TBL] [Abstract][Full Text] [Related]
14. Physiologic and cardiac roles of beta-arrestins.
Patel PA; Tilley DG; Rockman HA
J Mol Cell Cardiol; 2009 Mar; 46(3):300-8. PubMed ID: 19103204
[TBL] [Abstract][Full Text] [Related]
15. β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor-β arrestin scaffold-mediated activation of extracellular-regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra-neuraxial carcinoma.
Ghali GZ; Ghali MGZ
Mol Biol Rep; 2020 Jun; 47(6):4631-4650. PubMed ID: 32303958
[TBL] [Abstract][Full Text] [Related]
16. β2-Adrenergic receptor-dependent chemokine receptor 2 expression regulates leukocyte recruitment to the heart following acute injury.
Grisanti LA; Traynham CJ; Repas AA; Gao E; Koch WJ; Tilley DG
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15126-15131. PubMed ID: 27956622
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor.
Galandrin S; Denis C; Boularan C; Marie J; M'Kadmi C; Pilette C; Dubroca C; Nicaise Y; Seguelas MH; N'Guyen D; Banères JL; Pathak A; Sénard JM; Galés C
Hypertension; 2016 Dec; 68(6):1365-1374. PubMed ID: 27698068
[TBL] [Abstract][Full Text] [Related]
18. Heme enables proper positioning of Drosha and DGCR8 on primary microRNAs.
Partin AC; Ngo TD; Herrell E; Jeong BC; Hon G; Nam Y
Nat Commun; 2017 Nov; 8(1):1737. PubMed ID: 29170488
[TBL] [Abstract][Full Text] [Related]
19. beta-arrestin-biased agonism at the beta2-adrenergic receptor.
Drake MT; Violin JD; Whalen EJ; Wisler JW; Shenoy SK; Lefkowitz RJ
J Biol Chem; 2008 Feb; 283(9):5669-76. PubMed ID: 18086673
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-150 protects the mouse heart from ischaemic injury by regulating cell death.
Tang Y; Wang Y; Park KM; Hu Q; Teoh JP; Broskova Z; Ranganathan P; Jayakumar C; Li J; Su H; Tang Y; Ramesh G; Kim IM
Cardiovasc Res; 2015 Jun; 106(3):387-97. PubMed ID: 25824147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
